Colchicine and Cardiovascular Outcomes: a Critical Appraisal of Recent Studies.

"Declaration Conflict of InterestPEP owns four shares in AstraZeneca PLC and has received honoraria and/or travel reimbursement for events sponsored by AKCEA, Amgen, AMRYT, Link Medical, Mylan, Napp, Sanofi.MB reports Speakers bureau from the following: Abbott/Mylan, Akcea, Amgen, Daichii Sankyo, KRKA, MSD, Novartis, Novo-Nordisk, Polpharma, Sanofi, Servier; consultant to Akcea, Amgen, Daichii Sankyo, Esperion, Freia Pharmaceuticals, Herbapol, Kogen, MSD, Polfarmex, Resverlogix, Sanofi/Regeneron, Teva, Zentiva; Grants from Amgen, Mylan, Sanofi and Valeant. Human and Animal Rights and Informed ConsentThis article does not contain any studies with human or animal subjects performed by any of the authors. Conflict of Interest PEP owns four shares in AstraZeneca PLC and has received honoraria and/or travel reimbursement for events sponsored by AKCEA, Amgen, AMRYT, Link Medical, Mylan, Napp, Sanofi. MB reports Speakers bureau from the following: Abbott/Mylan, Akcea, Amgen, Daichii Sankyo, KRKA, MSD, Novartis, Novo-Nordisk, Polpharma, Sanofi, Servier; consultant to Akcea, Amgen, Daichii Sankyo, Esperion, Freia Pharmaceuticals, Herbapol, Kogen, MSD, Polfarmex, Resverlogix, Sanofi/Regeneron, Teva, Zentiva; Grants from Amgen, Mylan, Sanofi and Valeant."